EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access

Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen

Jean-Christophe Rozé, Gilles Cambonie, Cyril Flamant, Juliana Patkaï, Tobias Mühlbacher, Geraldine Gascoin, Aline Rideau Batista Novais, Manon Tauzin, Kevin Le Duc, Alain Beuchée, Sebastien Joye, Evgeniya Babacheva und 42 weitere

JAMA Pediatrics · 01.04.2026 · 180 (4) · 374

DOI: 10.1001/jamapediatrics.2025.6150 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JAMA Pediatrics, erschienen am 01.04.2026. Verfasst von Jean-Christophe Rozé und 53 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatal Medicine, Nantes University Hospital, Inserm, Centre d'Investigation Clinique 1413, Nantes, France. Hauptthemen laut MEDLINE: Acetaminophen, Ductus Arteriosus, Patent, Analgesics, Non-Narcotic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Controversies persist about management of the ductus arteriosus by nonsteroidal anti-inflammatory drugs in extremely preterm infants. Acetaminophen (paracetamol) appears to be a promising alternative with possibly fewer adverse effects.

Objective

To evaluate whether prophylactic intravenous acetaminophen started within 12 hours of birth increases survival without neonatal severe morbidities at 36 weeks’ postmenstrual age. Design, Setting, and Participants A double-blind, randomized, placebo-controlled clinical trial was conducted among preterm infants born between 23 weeks 0 days and 28 weeks 6 days of gestation in 43 neonatal intensive care units of 14 European countries between October 2020 (October 2021 for infants born at 23-26 weeks’ gestation, after the phase 2 study identified the optimal dose of acetaminophen) and April 2024. Data analysis was conducted from January to June 2025.

Intervention

In the acetaminophen group, patients born at 27 to 28 weeks’ gestation received a 20-mg/kg loading dose of acetaminophen followed by 7.5 mg/kg every 6 hours for 5 days, and patients born at 23 to 26 weeks’ gestation received a 25-mg/kg loading dose of acetaminophen followed by 10 mg/kg every 6 hours for 5 days. In the placebo group, isotonic sodium chloride was administered. Main Outcomes and Measures The primary outcome was survival without neonatal morbidity evaluated at 36 weeks’ postmenstrual age. The secondary exploratory outcome was ductus arteriosus closure, assessed by echocardiography on day 7.

Results

A total of 778 patients (median [IQR] gestational age, 26 [25-27] weeks; 375 [48.2%] female) were included in the study, with 391 in the acetaminophen group and 387 in the placebo group. Survival without severe morbidities at 36 weeks’ postmenstrual age occurred in 259 infants (66.2%) in the acetaminophen group and 246 (63.6%) in the placebo group (absolute risk difference [ARD], 2.7 [95% CI, −4.0 to 9.3] percentage points; relative risk [RR], 1.04 [95% CI, 0.94 to 1.16]). The ductus arteriosus was considered closed on day 7 in 264 of 371 infants (71.2%) assigned to acetaminophen and 191 of 366 infants (52.2%) assigned to placebo (ARD, 19.0 [95% CI, 12.0 to 25.7] percentage points; RR, 1.36 [95% CI, 1.21 to 1.53]). In the safety analysis, adverse events were not different except for a higher cholestasis rate in the acetaminophen group (25 of 392 infants [6.4%]) vs the placebo group (10 of 386 infants [2.6%]) (ARD, 3.8 [95% CI, 0.9 to 6.9]) percentage points. Conclusions and Relevance This study found that prophylactic acetaminophen treatment for patent ductus arteriosus did not increase survival without neonatal morbidities. Trial Registration ClinicalTrials.gov Identifier: NCT04459117

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcetaminophenDuctus Arteriosus, PatentAnalgesics, Non-NarcoticHumansDouble-Blind MethodFemaleInfant, NewbornMaleInfant, Extremely PrematureGestational AgeTreatment Outcome

Substanzen

AcetaminophenAnalgesics, Non-Narcotic

Autor:innen und Institutionen

  • Department of Neonatal Medicine, Nantes University Hospital, Inserm, Centre d'Investigation Clinique 1413, Nantes, France.
  • Department of Neonatal Medicine, Montpellier University Hospital, Montpellier, France.
  • Department of Neonatal Medicine, Cochin Port-Royal Hospital, Fédération Hospitalo-Universitaire PREMA, Assistance Publique-Hôpitaux de Paris Centre, Paris, France.
  • Newborn Research, Department of Neonatology, University Hospital and University of Zürich, Zürich, Switzerland.
  • Neonatal Intensive Care, University Hospital, Toulouse, France.
  • Department of Neonatology, Robert Debré Hospital, Assistance Publique-Hôpitaux de Paris, Paris, France.

Zitieren

APA

Rozé, J. C., Cambonie, G., Flamant, C., Patkaï, J., Mühlbacher, T., Gascoin, G., Rideau Batista Novais, A., Tauzin, M., Le Duc, K., Beuchée, A., Joye, S., Babacheva, E., Bouissou, A., Ligi, I., Tammela, O., Plourde, M., Dempsey, E., Tosello, B., Nguyen, K., …, & TREOCAPA Study Group (2026). Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen. JAMA Pediatrics, 180(4), 374. https://doi.org/10.1001/jamapediatrics.2025.6150

Vancouver

Rozé JC, Cambonie G, Flamant C, Patkaï J, Mühlbacher T, Gascoin G, et al. Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen. JAMA Pediatrics. 2026;180(4):374. doi:10.1001/jamapediatrics.2025.6150

BibTeX
@article{Roz2026,
  author = {Rozé, Jean-Christophe and Cambonie, Gilles and Flamant, Cyril and Patkaï, Juliana and Mühlbacher, Tobias and Gascoin, Geraldine and Rideau Batista Novais, Aline and Tauzin, Manon and Le Duc, Kevin and Beuchée, Alain and Joye, Sebastien and Babacheva, Evgeniya and Bouissou, Antoine and Ligi, Isabelle and Tammela, Outi and Plourde, Marion and Dempsey, Eugene and Tosello, Barthelemy and Nguyen, Kim and Vincent, Marine and Andresson, Pille and Binder, Christoph and Kruse, Charlotte and Barcos Munoz, Francisca and Kuhn, Pierre and Proença, Elisa and Bartocci, Marco and Kermorvant-Duchemin, Elsa and Nellis, Georgi and Lumia, Mirka and Giapros, Vasileios and Rigo, Vincent and Sankilampi, Ulla and Mendes da Graça, André and Rønnestad, Arild and Soukka, Hanna and Mondì, Vito and Aikio, Outi and Torre-Monmany, Nuria and Rüegger, Christoph and Baud, Olivier and Zeitlin, Jennifer and Morgan, Andrei Scott and Baruteau, Alban-Elouen and Ancel, Pierre-Yves and Carbajal, Ricardo and Bouazza, Naim and Diallo, Alpha and Levoyer, Lea and Kemper, Ruth and Hallman, Mikko and Alberti, Corinne and Ursino, Moreno and TREOCAPA Study Group, TREOCAPA Study Group},
  title = {Prophylactic Treatment of Patent Ductus Arteriosus With Acetaminophen},
  journal = {JAMA Pediatrics},
  year = {2026},
  volume = {180},
  number = {4},
  pages = {374},
  doi = {10.1001/jamapediatrics.2025.6150}
}
Kostenlos starten →